Whole-Body Cryotherapy to Help Endometriosis Pain
Official title: An Exploratory Clinical Trial to Determine the Impact of Whole-body Cryotherapy on Endometriosis-associated Pain
Run by University of Edinburgh · NCT07603960 · Data updated 2026-11-12
A small pilot study will test whether short exposures to extreme cold can reduce chronic pelvic pain and improve quality of life for people with endometriosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years and up |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | University of Edinburgh Academic / other |
| Locations | 1 site (Edinburgh, Scotland) |
| Status | Recruiting |
| Started | April 9, 2026 |
| Main results expected | November 2026 |
| Study ends | May 31, 2027 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT07603960 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women or people assigned female at birth aged 16 or older with confirmed endometriosis and chronic pelvic pain for more than six months who consent to the procedure and contraception use if needed.
✕Probably not a fit
Participants with conditions or factors that preclude safe cryotherapy or do not respond to anti-inflammatory strategies may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-site, single-arm pilot study will enroll up to 30 participants with symptomatic endometriosis and chronic pelvic pain for more than six months. Over about 12 months, participants will complete two hospital visits about four weeks apart and receive five WBCT sessions (about 3 minutes each) in a -120°C chamber between visits. The study will measure changes in systemic inflammation and other biological markers using blood, saliva, urine, vaginal, and stool samples, alongside patient-reported outcomes. It aims to assess feasibility, safety, acceptability, and preliminary efficacy of WBCT for endometriosis-related pain and quality of life, while exploring potential mechanisms of action.
Why it matters
Potential benefit: If successful, WBCT could offer a non-pharmacological option to help reduce pain and improve daily living for people with endometriosis.
How similar studies have gone: Prior studies in other conditions suggest anti-inflammatory and analgesic effects from cryotherapy, but its use for endometriosis is novel and has not been established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women or assigned female at birth * Aged 16 or over * Endometriosis identified at laparoscopy or imaging, performed within the last ten years * Chronic pelvic pain for more than six months * Willing to comply with the treatment * Willing to use effective contraception throughout the trial (if needed) * Willing and able to give informed consent Exclusion Criteria: * Pregnant, breastfeeding or actively trying to get pregnant * Post-menopausal (no periods for \>12 months and not taking hormonal treatments to prevent periods, or bilateral oophorectomy performed) * Previous hysterectomy with bilateral oophorectomy * Raynaud's Disease * Current treatment for malignancy * Diabetes * Known hypothyroidism * Pre-existing or current diagnosis of anaemia * Cardiovascular disease: severe hypertension (180/100, unstable angina, arrhythmia, recent (\<6months) myocardial infarction, peripheral artery disease, cardiac pacemaker, recent (\<6months) stroke or transient ischaemic attack) * Acute kidney and urinary tract diseases * Cryoglobulinemia * Previous venous thromboembolism or peripheral artery occlusive disease * Cold urticaria * Livedo reticularis * Open wounds or ulcers, large-area bacterial and viral skin infections * Uncontrolled seizure disorder * Known coagulopathy (eg von Willibrand disease, haemophilia) * Severe claustrophobia * Acute infections and fever * Intoxication (alcohol, drugs) * Signs or symptoms of cold allergy * Severe wasting diseases * Known Hepatitis B/C and/or HIV (due to Royal Mail restrictions on biospecimen postage)
Where it's running
-
Institute for Regeneration and Repair, University of Edinburgh and Royal Infirmary of Edinburgh
Edinburgh, Scotland, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Imaging endometriosis with a special PET tracer in adult women
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
-
Atypical Endometriosis: Histology, Immunophenotype and Molecular Features
Researchers will look at how endometriotic tissue that looks atypical under the microscope relates to clinical features and ultrasound findings to better separate benign from potentially atypical lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.